AjaxTherapeutics
@ajaxthx
ID: 1399497737893302278
31-05-2021 22:47:30
24 Tweet
146 Followers
8 Following
Ajax Announcement #2. The IND for our lead molecule, AJ-101095, a potent selective type II JAK inhibitor, has been cleared by the FDA. Next stop->clinic. Let's go!. ajaxtherapeutics.com/ajax-therapeut… David Steensma, MD